Shares of pharmaceutical company Aurobindo Pharma rose over 3% in trade on Monday, August 31, after the company announced that its subsidiary had launched a product in the US market.
Following the announcement, Aurobindo Pharma’s share price rose 3.5% to hit an intra-day high of Rs 1,703 apiece on the NSE. Although the stock pared some of its gains, it continued to see strong buying interest.